Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Migliaccio I et al. – Nuclear Insulin receptor substrate–1 (IRS–1) may be a useful marker to predict tamoxifen response in patients with early breast cancer, particularly when assessed in combination with PR.


Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address